Conversely, semaglutide, with strong cardiovascular outcomes and weight-loss efficacy, may be better suited for individuals with obesity, T2DM, or high cardiometabolic risk, where it can improve histology and provide extra-hepatic benefits through calorie reduction and glycemic control
It does not indicate poor solubility or quality
Viking Therapeutics' VK-2735 - The New Kid On The Block Fresh off the press Viking reported statistically significant weight loss of 13% at 13-weeks, which didnt show signs of plateauing
Brown or green indicates oxidation
Supplements are not intended to diagnose, treat, cure, mitigate or prevent any disease
For patients with metabolic syndrome, that's often more valuable than another 20 mg/dL drop in LDL